Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary systems

Journal of Pharmaceutical and Biomedical Analysis

Volumn 35, Issue 1, 2004, Pages 75-86

  Naidu, N Buchi ^a,b   Chowdary, K P R ^a   Murthy, K V R ^a   Satyanarayana, V ^b   Hayman, A R ^c   Becket, G ^c  

^a ANDHRA UNIVERSITY   (India)

^b University of Kentucky   (United States)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cyclodextrins; Dissolution properties; Meloxicam; Physicochemical characterization

Indexed keywords

ALPHA CYCLODEXTRIN; BETA CYCLODEXTRIN; CYCLODEXTRIN; GAMMA CYCLODEXTRIN; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT;

ANALYTIC METHOD; ARTICLE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRUG SOLUTION; MASS SPECTROMETRY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCANNING ELECTRON MICROSCOPY; SOLID; SOLID STATE; X RAY POWDER DIFFRACTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALORIMETRY, DIFFERENTIAL SCANNING; CYCLODEXTRINS; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR STRUCTURE; SOLUBILITY; SOLUTIONS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SURFACE PROPERTIES; THIAZINES; THIAZOLES; X-RAY DIFFRACTION;

EID: 1642399085     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2004.01.003     Document Type: Article

References (15)

1. Engelhardt G., Homma D., Schlegel K., Schnitzeler C., Utzmann R. Inflamm. Res. 44:1995;423-433.
2. Engelhardt G., Bogel R., Schnitzeler C., Utzmann R. Biochem. Pharmacol. 51:1996;21-28.
3. Churchill L., Graham A.G., Shih C.K., Pauletti D., Farina P.R., Grob P.M. Inflamm. Pharmacol. 4:1996;125-135.
4. M. Pairet, G. Engelhardt, in: J. Vane, J. Botting, R. Botting (Eds.), Improved Nonsteroidal Anti Inflammatory Drugs - COX-2 Enzyme Inhibitors, Kluwer Academic Publishers, Dordrecht, 1996, pp. 103-119.
5. Distel M., Mueller C., Bluhmki E. Inflamm. Pharmacol. 4:1996;71-81.
6. Truck D., Busch U., Heinzel G., Narjes H. Drug Res. 47:1997;253-258.
7. Duchene D., Wouessidjewe D. Drug Dev. Ind. Pharm. 16:1990;2487-2499.
8. Bekers O., Uijtendal E.V., Beijnen J.H., Bult A., Underberg W.J. Drug Dev. Ind. Pharm. 17:1991;1503-1549.
9. T. Higuchi, K.A. Connors, in: C.N. Reilly (Ed.), Advances in Analytical Chemistry Instrumentation, Interscience, New York, vol. 4, 1965, pp. 117-212.
10. Ryan J.A. J. Pharm. Sci. 75:1986;805-807.
11. Khan K.A. J. Pharm. Pharmacol. 27:1975;48-49.
12. Corrigan O.I., Stanley T. J. Pharm. Pharmacol. 34:1982;621-626.
13. Donbrow M., Touitou E. J. Pharm. Sci. 67:1978;95-98.
14. Uekama K., Narisawa S., Hirayama F., Otagiri M. Int. J. Pharm. 16:1983;327-338.
15. Gandhi R., Karara A.H. Drug Dev. Ind. Pharm. 14:1988;657-682.